Overview

Pilot Bioequivalency Study of Exemestane 25 mg Tablet Under Fasted Conditions

Status:
Completed
Trial end date:
2004-05-01
Target enrollment:
Participant gender:
Summary
The objective of this study was to prove the bioequivalence of Exemestane 25 mg tablet under fasted conditions
Phase:
N/A
Details
Lead Sponsor:
Roxane Laboratories
Treatments:
Exemestane